| 2001 |
FANCD2 is a novel 1451 amino acid nuclear protein encoded by a gene with 44 exons; retroviral transduction of FANCD2 cDNA into FA-D2 cells complemented MMC sensitivity, establishing it as the FA complementation group D2 gene product. |
Positional cloning, retroviral complementation assay |
Molecular cell |
High |
11239453
|
| 2002 |
FANCD2 undergoes monoubiquitination at K561 during S phase and in response to DNA damage, and monoubiquitinated FANCD2 colocalizes with BRCA1 and RAD51 in S-phase nuclear foci; monoubiquitination is required for normal cell-cycle progression following MMC exposure. |
Immunofluorescence co-localization, cell fractionation, mutational analysis (K561R) |
Blood |
High |
12239151
|
| 2002 |
FANCD2 interacts with NBS1; ionizing radiation activates ATM-dependent, NBS1-dependent phosphorylation of FANCD2 to mediate an S-phase checkpoint, while MMC activates colocalization of FANCD2 and NBS1 in subnuclear foci. |
Co-immunoprecipitation, immunofluorescence, S-phase checkpoint assay |
Nature cell biology |
High |
12447395
|
| 2003 |
The purified BRCA1/BARD1 complex reconstitutes monoubiquitination of FANCD2 in vitro with E1 and UbcH5a; however, BRCA1/BARD1 E3 ligase activity is not essential for in vivo FANCD2 monoubiquitination, whereas BRCA1 is required for FANCD2 targeting to DNA damage sites. |
In vitro ubiquitination reconstitution, siRNA knockdown, RING domain mutagenesis in chicken DT40 cells |
Molecular cell |
High |
12887909
|
| 2004 |
ATR kinase and RPA1 are required for efficient FANCD2 monoubiquitination and assembly of FANCD2 nuclear foci; deficiency of ATR results in radial chromosomes upon MMC treatment, mimicking FA chromosome instability. |
siRNA silencing, cell line analysis (Seckel syndrome), immunofluorescence, chromosome analysis |
Genes & development |
High |
15314022
|
| 2004 |
FANCD2 directly interacts with BRCA2 at a conserved C-terminal site; FANCD2 and BRCA2 co-immunoprecipitate from human and hamster cell extracts; FANCD2 colocalizes with RAD51 and PCNA following replication fork stalling, suggesting a role in repair of replication-associated DSBs. |
Yeast two-hybrid, co-immunoprecipitation, immunofluorescence co-localization |
Human molecular genetics |
High |
15115758
|
| 2004 |
Monoubiquitination of FANCD2 at K561 is required for chromatin binding; the C-terminal residue D1428 encoded by exon 44 is independently required for functional complementation; a FANCD2-K561R mutant fails to bind chromatin. |
Stable transfection of FANCD2 mutants in FANCD2-/- fibroblasts, chromatin fractionation, MMC sensitivity assay |
Blood |
High |
15454491
|
| 2004 |
ICL-induced S-phase checkpoint requires ATR kinase; FANCD2 is phosphorylated in an ATR-dependent manner and ATR colocalizes with FANCD2; the checkpoint involves parallel branches: CHK1 and FANCs/NBS1 acting downstream of ATR. |
siRNA, immunofluorescence, S-phase checkpoint assays, kinase inhibition |
The EMBO journal |
High |
14988723
|
| 2007 |
FANCI is a paralog of FANCD2 that associates with FANCD2 to form the ID complex on chromatin in response to DNA damage; FANCI is monoubiquitinated, and ubiquitination of each protein (FANCI and FANCD2) is required to maintain ubiquitin on the other, revealing a dual ubiquitin-locking mechanism. |
Mass spectrometry identification, co-immunoprecipitation, chromatin fractionation, monoubiquitination assays |
Cell |
High |
17412408
|
| 2007 |
USP1 deubiquitinase removes monoubiquitin from FANCD2; USP1 disruption causes constitutively chromatin-bound monoubiquitinated FANCD2 and crosslinker sensitivity, demonstrating that FANCD2 deubiquitination is required for efficient DNA crosslink repair. |
USP1 gene disruption in chicken DT40 cells, chromatin fractionation, MMC sensitivity assay |
Molecular cell |
High |
18082605
|
| 2008 |
FANCG promotes formation of a complex containing BRCA2, FANCD2, and XRCC3; phosphorylation of FANCG serine 7 is required for co-precipitation of BRCA2, XRCC3, and FANCD2; FANCG and XRCC3 are epistatic for sensitivity to crosslinking agents. |
Co-immunoprecipitation, phosphorylation site mutagenesis, DT40 genetic epistasis |
Oncogene |
Medium |
18212739
|
| 2009 |
Monoubiquitinated FANCD2 colocalizes with telomeres and PML bodies in ALT cells; FA core complex components FANCA and FANCL regulate FANCD2 monoubiquitination and its telomeric localization; FANCD2 depletion causes loss of detectable telomeres and decreased T-SCE in ALT cells. |
siRNA knockdown, immunofluorescence co-localization, T-SCE assay |
Nucleic acids research |
Medium |
19129235
|
| 2009 |
FANCM chromatin binding and DNA damage-induced phosphorylation are partially regulated by the downstream FA pathway protein FANCD2 in Xenopus egg extracts. |
Xenopus egg extract system, immunodepletion, chromatin fractionation |
The Journal of biological chemistry |
Medium |
19633289
|
| 2010 |
FAN1 (KIAA1018) interacts with monoubiquitinated FANCD2 and is recruited to sites of DNA damage by monoubiquitinated FANCD2; FAN1 has 5' flap endonuclease and 5' exonuclease activities mediated by a VRR_nuc domain; FAN1 depletion causes ICL hypersensitivity. |
Co-immunoprecipitation, in vitro nuclease assay, siRNA depletion, ICL repair assay |
Cell |
High |
20603015
|
| 2010 |
RAD18 E3 ubiquitin ligase binds FANCD2 and is required for efficient monoubiquitylation and chromatin localization of both FANCD2 and FANCI; the RING domain of RAD18 is required for this interaction and chromatin loading. |
Co-immunoprecipitation, RAD18 knockout cells, chromatin fractionation, RING domain mutagenesis |
Blood |
Medium |
21355096
|
| 2010 |
Fancd2-deficient mouse bone marrow shows decreased HSC frequency (Lin-Sca-1+Kit+ and SLAM marker populations) and defective long-term in vivo repopulating ability, establishing FANCD2 as required for hematopoietic stem cell maintenance. |
Fancd2-/- mouse model, flow cytometry, cobblestone area-forming cell assay, transplantation |
Stem cells |
High |
20506303
|
| 2011 |
Crystal structure of the ~300 kDa FANCI-FANCD2 (ID) complex at 3.4 Å reveals that monoubiquitination and regulatory phosphorylation sites map to the I-D interface; both proteins have binding sites for single- and double-stranded DNA, suggesting the ID complex recognizes DNA structures at stalled replication forks. |
X-ray crystallography, electron density mapping of FANCI-DNA crystals, in vitro DNA binding |
Science |
High |
21764741
|
| 2012 |
FANCD2 contains a CUE ubiquitin-binding domain that mediates noncovalent ubiquitin binding in vitro; the CUE domain is required for interaction with FANCI, chromatin retention of monoubiquitinated FANCD2 and FANCI, and efficient ICL repair. |
CUE domain mutagenesis, in vitro ubiquitin binding assay, co-immunoprecipitation, ICL repair assay |
Blood |
Medium |
22855611
|
| 2012 |
DNA robustly stimulates FANCD2 monoubiquitylation in the FANCI-FANCD2 complex in vitro; this stimulation strictly requires FANCI and FANCI's DNA binding activity; 5' flapped DNA (mimicking arrested replication forks) achieves ~70% monoubiquitylation in vitro. |
In vitro ubiquitylation reconstitution with purified proteins and various DNA substrates, FANCI DNA binding mutants |
Nucleic acids research |
High |
22287633
|
| 2012 |
DNA damage-induced FA pathway activation triggers dissociation of FANCD2 from FANCI; FANCI phosphorylation is the molecular trigger for dissociation; FANCD2 monoubiquitination significantly precedes FANCI monoubiquitination; FANCD2 binds replicating chromatin prior to and independently of FANCI. |
Co-immunoprecipitation, chromatin fractionation, phosphomimetic/phosphodead FANCI mutants |
Nucleic acids research |
Medium |
22753026
|
| 2013 |
Monoubiquitinated FANCD2 (FANCD2-Ub) activates transcription of the tumor suppressor TAp63 to promote cellular senescence and block skin tumorigenesis; Usp1-deficient mice with elevated FANCD2-Ub are resistant to skin tumors while Fancd2-deficient mice are susceptible. |
Fancd2-/- and Usp1-/- mouse models, Ras-driven skin carcinogenesis, TAp63 transcription assay |
Molecular cell |
High |
23806336
|
| 2013 |
mTOR regulates FANCD2 expression through NF-κB; mTOR loss increases NF-κB nuclear translocation and NF-κB binding to the FANCD2 promoter, suppressing FANCD2 expression; exogenous FANCD2 rescues the DDR defect caused by mTOR inhibition. |
mTOR gene targeting in HSPCs, NF-κB ChIP at FANCD2 promoter, rescue by FANCD2 re-expression |
Leukemia |
Medium |
23538752
|
| 2014 |
XPF-ERCC1 cooperates with SLX4/FANCP to carry out DNA unhooking incisions during ICL repair in Xenopus egg extracts; efficient recruitment of XPF-ERCC1 and SLX4 to ICLs depends on FANCD2 and its monoubiquitination. |
Xenopus egg extract ICL repair system, immunodepletion, site-specific ICL substrates |
Molecular cell |
High |
24726325
|
| 2014 |
The genetic and biochemical basis of FANCD2 monoubiquitination: purified native FA core complex reconstitutes FANCD2 monoubiquitination in vitro; FANCL must be embedded in the complex for maximal activity and site specificity; a minimal FANCB-FANCL-FAAP100 subcomplex functions as the monoubiquitination module. |
Purification of native avian FA core complex, in vitro ubiquitination reconstitution, genetic dissection of minimal complex |
Molecular cell |
High |
24905007
|
| 2014 |
Monoubiquitinated FANCD2 tethers CtIP to damaged chromatin via physical interaction; this channels ICL-generated DSBs into HR; CtIP mutants defective in FANCD2 binding fail to associate with damaged chromatin and show increased NHEJ and ICL hypersensitivity. |
Co-immunoprecipitation, chromatin fractionation, ICL sensitivity assay, HR/NHEJ reporter assays |
Cell reports |
Medium |
24794434
|
| 2014 |
CtIP is a novel interaction partner of FANCD2; CtIP binds and stabilizes FANCD2 in a DNA damage- and FA core complex-independent manner; FANCD2 recruits CtIP to stalled replication forks to promote fork restart and suppress new origin firing, dependent on BRCA1. |
Co-immunoprecipitation, DNA fiber assay, chromatin fractionation, siRNA knockdown |
Human molecular genetics |
Medium |
24556218
|
| 2015 |
FANCI, but not FANCD2, is needed for efficient FA core complex foci formation; FANCI functions upstream of FA core complex recruitment independently of FANCD2; FANCD2 monoubiquitination is not required for this FANCI function, but USP1-mediated FANCI deubiquitination is. |
siRNA, FANCI/FANCD2 knockout cell lines, immunofluorescence foci assay |
PLoS genetics |
Medium |
26430909
|
| 2015 |
FANCD2 cooperates with BRCA2 and RAD51 to protect stalled replication forks from nucleolytic degradation and recruits BLM helicase to promote replication fork restart while suppressing new origin firing. |
DNA fiber assay, siRNA knockdown, co-immunoprecipitation, replication restart assays |
Human molecular genetics |
Medium |
24556218
|
| 2015 |
REV1 is recruited to DNA damage sites via its ubiquitin-binding motifs and monoubiquitinated FANCD2, acting downstream of RAD18; FANCD2 and REV1 are epistatic for camptothecin sensitivity; REV1 protects nascent replication tracts from degradation by stabilizing RAD51 filaments. |
Laser stripe recruitment assay, FANCD2-Ub chimeric protein expression, DNA fiber assay, epistasis analysis |
Nucleic acids research |
Medium |
26187992
|
| 2016 |
FANCD2-FANCI complex is recruited to stalled replication forks before monoubiquitination; cryo-EM structure of the human complex reveals an inner cavity large enough for dsDNA and a Tower domain harboring disease-causing mutations; fork recruitment triggers the activating monoubiquitination. |
Cryo-EM structure determination, disease mutation mapping, reconstitution assays |
Nature communications |
High |
27405460
|
| 2016 |
FANCD2 is required for fork protection and fork restart in BRCA1/2-deficient tumors; FANCD2 promotes Polθ recruitment at damage sites and alt-EJ repair; loss of FANCD2 in BRCA1/2-deficient tumors enhances cell death, revealing a synthetic lethal relationship. |
DNA fiber assay, siRNA in BRCA1/2-deficient cell lines, alt-EJ reporter, xenograft tumor model |
Cell reports |
High |
27264184
|
| 2016 |
Monoubiquitinated FANCD2 acts in opposition to BLM helicase at ALT telomeres; FANCD2 depletion causes hyper-ALT phenotype including increased extrachromosomal telomeric repeats; increases are suppressed by BLM but not RAD51 loss. |
siRNA depletion, FANCD2/BLM double knockdown, telomere FISH, C-circle assay |
Human molecular genetics |
Medium |
27427384
|
| 2017 |
FANCD2 has two major DNA binding domains consisting of conserved lysine residues; an N-terminal domain also contains nuclear localization sequences; mutations in the bifunctional DNA binding/NLS domain reduce FANCD2 monoubiquitination and increase MMC sensitivity. |
Synthetic peptide mapping, electromobility shift assay, NLS mutagenesis, complementation assay |
Nucleic acids research |
Medium |
28666371
|
| 2017 |
FANCD2 interacts with RNA processing factors hnRNP U and DDX47; FANCD2 recruits these factors to chromatin at large fragile genes and promotes efficient processing of long RNA transcripts, thereby suppressing R-loop levels during mild replication stress. |
Co-immunoprecipitation/mass spectrometry, ChIP-seq, PLA, siRNA knockdown, R-loop detection |
The FEBS journal |
Medium |
30431240
|
| 2017 |
FANCD2 functionally impacts mitochondrial ATP production through interaction with ATP5α; monoubiquitinated FANCD2 is required for this interaction and for proper mitochondrial localization of ATP5α; non-monoubiquitinated FANCD2 (K561R) fails to interact with ATP5α and cells show reduced mitochondrial ATP production. |
Co-immunoprecipitation, mitochondrial fractionation, ATP production assay, protein docking |
Scientific reports |
Low |
28687786
|
| 2017 |
FANCI and FANCD2 associate with the spliceosomal protein SF3B1; DNA replication stress induces ATR- and FANCI-dependent release of SF3B1 from nuclear speckles; both FANCD2 and FANCI prevent accumulation of postcatalytic intron lariats in chromatin. |
Co-immunoprecipitation, proximity ligation assay, immunofluorescence, lariat RT-PCR |
The Journal of cell biology |
Medium |
29030393
|
| 2018 |
FANCD2 accumulates at the central regions of large fragile genes during replication stress in an R-loop-dependent manner; FANCD2 monoubiquitination and RPA foci formation are still induced after R-loop depletion; increased FANCD2-R-loop proximity is detected by PLA following aphidicolin treatment. |
ChIP-seq, PLA, siRNA depletion of R-loops (RNaseH1 overexpression), immunofluorescence |
Nucleic acids research |
Medium |
29394375
|
| 2019 |
FANCL allosterically activates UBE2T (E2) to drive site-specific FANCD2 monoubiquitination; FANCL rewires the intraresidue network of UBE2T to engage an acidic patch near K561 on FANCD2 through a basic triad unique to UBE2T. |
In vitro ubiquitination reconstitution, NMR, mutagenesis of UBE2T active site, site-specificity assays |
Nature chemical biology |
High |
31873223
|
| 2019 |
Efficient FANCD2 deubiquitination by USP1-UAF1 requires DNA and DNA-binding by UAF1; RAD51AP1's DNA binding activity can substitute for UAF1 DNA binding in FANCD2 deubiquitination; UAF1 and RAD51AP1 DNA binding is important for FANCD2 deubiquitination in cells. |
Biochemical reconstitution with purified proteins, UAF1/RAD51AP1 mutants, cellular deubiquitination assays |
Nature communications |
High |
31253762
|
| 2019 |
Nuclear receptors COUP-TFII and TR4 directly interact with FANCD2 and form a complex that recruits MUS81 endonuclease and PCNA-POLD3 replication complex to ALT telomeres; this noncanonical FANCD2 pathway operates independently of the FA core complex or FANCD2 monoubiquitination. |
Co-immunoprecipitation, ChIP at telomeres, gene knockdown, telomere function assays |
Science advances |
Medium |
31633027
|
| 2020 |
Monoubiquitination of FANCD2 (not FANCI) stabilizes the FANCI:FANCD2 heterodimer on dsDNA by clamping; monoubiquitinated FANCI:FANCD2 forms filament-like arrays on long dsDNA as shown by electron microscopy; monoubiquitination does not promote specific exogenous protein-protein interactions. |
FA pathway reconstitution in vitro, electron microscopy, DNA binding assays, protein-protein interaction screen |
eLife |
High |
32167469
|
| 2020 |
FANCD2 ubiquitination promotes a large-scale conformational change in the ID2 complex, increasing its affinity for dsDNA by forming a secondary 'Arm' ID2 interface that encircles DNA; FANCI ubiquitination protects the ubiquitin on FANCD2 from USP1-UAF1 deubiquitination. |
Biochemical ubiquitination assay, DNA binding assays, deubiquitination protection assay, structural analysis |
EMBO reports |
High |
32510829
|
| 2020 |
ATR directly phosphorylates FANCI on S556, S559, and S565 to stabilize its association with DNA and FANCD2, stimulating ubiquitination of both FANCI and FANCD2 and inhibiting USP1:UAF1 deubiquitination; S559 and S565 are particularly important for protection from deubiquitination. |
Biochemical reconstitution with purified ATR, FANCI phosphomimetic/phosphodead mutants, in vitro ubiquitination and deubiquitination assays |
Frontiers in cell and developmental biology |
High |
32117957
|
| 2021 |
Crystal structures of USP1-UAF1 with ubiquitin and cryo-EM of USP1-UAF1 bound to monoubiquitinated FANCI-FANCD2 reveal that USP1-UAF1 drives conformational changes in FANCI-FANCD2 for deubiquitination; UAF1 forms an extensive interface with FANCI required for deubiquitination despite not being directly catalytic. |
X-ray crystallography (USP1-UAF1), cryo-EM (USP1-UAF1-monoUb-ID complex), mutagenesis, biochemical deubiquitination assay |
Nature structural & molecular biology |
High |
33795880
|
| 2022 |
ATR phosphorylation of FANCI destabilizes the open state of FANCD2-FANCI and alters its conformational dynamics, priming the clamp for ubiquitination; cryo-EM structures of phosphomimetic FANCI-containing FANCD2-FANCI show complex closure around DNA independent of the FA core complex. |
Cryo-EM structure determination of phosphomimetic FANCD2-FANCI complexes, DNA binding assays, conformational dynamics analysis |
Nature structural & molecular biology |
High |
36050501
|
| 2024 |
FANCD2-FANCI acts as a sliding clamp that diffuses on dsDNA and specifically stalls at ss-dsDNA junctions (structures generated at stalled replication forks); cryo-EM structures show that stalled D2-I makes specific contacts with the ss-dsDNA junction distinct from those made when sliding, providing a unified mechanism for recognition and protection of stalled replication forks. |
Single-molecule imaging (sliding assay), cryo-EM structure determination, in vitro DNA binding at various junction substrates |
Nature |
High |
39085614
|
| 2024 |
SRSF1 physically interacts with FANCD2 and stimulates its monoubiquitination in an RNA-dependent manner; monoubiquitinated FANCD2 is required for assembly of the SRSF1-NXF1 nuclear export complex and mRNA export; SRSF1 cancer-associated mutants fail to interact with FANCD2, leading to reduced monoubiquitination, decreased mRNA export, and R-loop accumulation. |
Co-immunoprecipitation, FANCD2 monoubiquitination assay, mRNA export assay, R-loop detection (DRIP), cancer mutant analysis |
Cell reports |
Medium |
38165804
|
| 2014 |
Fancd2 is required for nuclear retention of Foxo3a in hematopoietic stem cells; Fancd2 deficiency promotes cytoplasmic localization of Foxo3a; re-expression of Fancd2 restores nuclear Foxo3a; this function requires monoubiquitinated Fancd2. |
Fancd2/Foxo3a double-knockout mouse, immunofluorescence subcellular localization, rescue by Fancd2 re-expression with constitutively active FOXO3a |
The Journal of biological chemistry |
Medium |
25505262
|
| 2018 |
The N-terminus of USP1 harbors a FANCD2-specific binding sequence required for deubiquitination of K561 on FANCD2; this N-terminal determinant is not required for PCNA or FANCI deubiquitination; the N-terminus alone is sufficient to engineer substrate specificity in a promiscuous USP. |
In vitro reconstituted deubiquitination of purified monoubiquitinated FANCD2/FANCI/PCNA, USP1 N-terminal truncation/mutants |
Life science alliance |
High |
30456385
|
| 2013 |
DNA polymerase eta is recruited to DNA damage sites by monoubiquitinated FANCD2 (not the K561R mutant); pol eta interacts with wild-type FANCD2 and this interaction occurs earlier than pol eta-PCNA interaction; FANCD2-null cells expressing FANCD2 or histone H2B-fused pol eta show similar low MMC sensitivity. |
Co-immunoprecipitation, MMC sensitivity assay, complementation with FANCD2 and pol eta constructs |
Cell cycle |
Low |
23388460
|